» Articles » PMID: 35304757

Ability of Matrix Metalloproteinase-8 Biosensor, IFMA, and ELISA Immunoassays to Differentiate Between Periodontal Health, Gingivitis, and Periodontitis

Overview
Specialty Dentistry
Date 2022 Mar 19
PMID 35304757
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The aim of this study was to determine the diagnostic utility of an MMP-8 biosensor assay in differentiating periodontal health from gingivitis and periodontitis and compare it with an established time-resolved immunofluorescence assay (IFMA) and enzyme-linked immunosorbent assay (ELISA).

Background: Currently available antibody-based assays display a wide variability in their ability to accurately measure matrix metalloproteinase-8 (MMP-8) levels in saliva.

Methods: Salivary MMP-8 levels were analyzed in 189 systemically healthy participants using an antibody-based biosensor prototype that operates using a surface acoustic wave technology and compared with IFMA and ELISA antibody assays. Participants were categorized into 3 groups: periodontal health (59), gingivitis (63), and periodontitis (67). A sub-population of participants (n = 20) with periodontitis received periodontal treatment and were monitored for 6 months.

Results: All the assays demonstrated significantly higher salivary MMP-8 concentrations in participants with periodontitis versus gingivitis, periodontitis versus health, and gingivitis versus health (all p < .05). The biosensor data demonstrated significant correlations with IFMA (r = .354, p < .001) and ELISA (r = .681, p < .001). Significant reductions in salivary MMP-8 concentrations were detected by the biosensor (p = .030) and IFMA (p = .002) in participants with periodontitis 6 months after non-surgical periodontal treatment. IFMA had the best sensitivity (89.2%) for detecting periodontitis and gingivitis versus health and 96.6% for detecting periodontitis versus health and gingivitis. The biosensor had an AUC value of 0.81 and diagnostic accuracy of 74.2% for differentiating periodontitis and gingivitis from health; an AUC value of 0.86 and diagnostic accuracy of 82.8% for periodontitis versus health and gingivitis.

Conclusions: The biosensor, IFMA, and ELISA assays differentiated between periodontal health, gingivitis, and periodontitis based on salivary MMP-8 levels. Only the biosensor and, particularly, IFMA identified an effect of periodontal treatment in the participants with periodontitis. Our findings support the potential utility of salivary oral fluid aMMP-8-based point-of-care technology in the future of periodontal diagnostics.

Citing Articles

Assessment of salivary matrix metalloproteinase (MMP8) and activated salivary matrix metalloproteinase (aMMP8) in periodontitis patients: a systematic review and meta-analysis.

Boynes S, Sofiyeva N, Saw T, Nieto V, Palomo L Front Oral Health. 2025; 6:1444399.

PMID: 40045958 PMC: 11880025. DOI: 10.3389/froh.2025.1444399.


Evaluating salivary MMP-8 as a biomarker for periodontal diseases: A systematic review and meta-analysis.

Domokos Z, Simon F, Uhrin E, Szabo B, Vancsa S, Varga G Heliyon. 2024; 10(22):e40402.

PMID: 39641024 PMC: 11617734. DOI: 10.1016/j.heliyon.2024.e40402.


Point-of-care diagnostic devices for periodontitis - current trends and urgent need.

Griffith A, Chande C, Kulkarni S, Morel J, Cheng Y, Shimizu E Sens Diagn. 2024; 3(7):1119-1134.

PMID: 39007012 PMC: 11238172. DOI: 10.1039/d3sd00317e.


Impact of Inflammatory Markers and Senescence-Associated Secretory Phenotype in the Gingival Crevicular Fluid on the Outcomes of Periodontal Regeneration.

Baima G, Romano F, Franco F, Roato I, Mussano F, Berta G Int J Mol Sci. 2024; 25(12).

PMID: 38928390 PMC: 11204308. DOI: 10.3390/ijms25126687.


Exploring the Efficacy of Novel Therapeutic Strategies for Periodontitis: A Literature Review.

Radu C, Radu C, Arbanasi E, Hogea T, Murvai V, Chis I Life (Basel). 2024; 14(4).

PMID: 38672739 PMC: 11050937. DOI: 10.3390/life14040468.


References
1.
Lahteenmaki H, Umeizudike K, Heikkinen A, Raisanen I, Rathnayake N, Johannsen G . aMMP-8 Point-of-Care/Chairside Oral Fluid Technology as a Rapid, Non-Invasive Tool for Periodontitis and Peri-Implantitis Screening in a Medical Care Setting. Diagnostics (Basel). 2020; 10(8). PMC: 7460514. DOI: 10.3390/diagnostics10080562. View

2.
Kassebaum N, Bernabe E, Dahiya M, Bhandari B, Murray C, Marcenes W . Global burden of severe periodontitis in 1990-2010: a systematic review and meta-regression. J Dent Res. 2014; 93(11):1045-53. PMC: 4293771. DOI: 10.1177/0022034514552491. View

3.
Alassiri S, Parnanen P, Rathnayake N, Johannsen G, Heikkinen A, Lazzara R . The Ability of Quantitative, Specific, and Sensitive Point-of-Care/Chair-Side Oral Fluid Immunotests for aMMP-8 to Detect Periodontal and Peri-Implant Diseases. Dis Markers. 2018; 2018:1306396. PMC: 6098860. DOI: 10.1155/2018/1306396. View

4.
Zhang L, Li X, Yan H, Huang L . Salivary matrix metalloproteinase (MMP)-8 as a biomarker for periodontitis: A PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2018; 97(3):e9642. PMC: 5779768. DOI: 10.1097/MD.0000000000009642. View

5.
Sorsa T, Gursoy U, Nwhator S, Hernandez M, Tervahartiala T, Leppilahti J . Analysis of matrix metalloproteinases, especially MMP-8, in gingival creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol 2000. 2015; 70(1):142-63. DOI: 10.1111/prd.12101. View